$ADNT

Herberg David sold $16K of ADNT

Herberg David (EVP, EMEA) sold 699 shares of Adient plc (ADNT) at $22.58 on 2026-06-04.

Original reporting
SEC EDGAR · Herberg David
Published Jun 5, 2026, 8:14 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ADNT
Neutral
medium confidence
Mentioned
$ADNT
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ADNTNeutralLow
01

Why it matters

This disclosure may slightly affect short-term sentiment, but there is no accompanying guidance, deal, or operational update.

02

Market read

Traders may monitor for follow-on insider activity, but this single small sale is unlikely to drive a major repricing.

03

What to watch

The absolute size ($15.8k) is small relative to typical institutional flows, reducing the likelihood of a sustained price move.

Relevance 5/10Novelty 6/10Timing: After-hours/next-session read-through from a 2026-06-04 insider sale filed 2026-06-05

Background

SEC Form 4 discloses insider transactions; these are often routine and primarily useful for sentiment/positioning rather than new fundamentals.

Company-level read

Ticker impact

$ADNTNeutralMedium confidence
Context

Adient’s EVP, EMEA (Herberg David) sold 699 shares in an open-market transaction disclosed via SEC Form 4 on 2026-06-04.

Expected impact

Low near-term impact; any reaction is likely limited to sentiment/positioning rather than fundamentals.

Evidence & confidence

The filing is a routine insider sale with no 10b5-1 plan stated and no accompanying operational/financial news, so it typically has limited price impact unless unusually large or paired with other disclosures.

Market effects

Minimal; this is company-specific insider activity with no stated sector-wide change.

None indicated.

None indicated.

Counterpoint

Without a stated 10b5-1 plan, the sale could reflect diversification or personal liquidity rather than bearish expectations.

Key entities

  • Adient plc

    Subject of the insider transaction disclosure (EVP, EMEA sale).

  • Herberg David

    EVP, EMEA who sold 699 shares at $22.58 on 2026-06-04.

Related articles

$ADNTMed

Adient misses earnings estimates despite stronger-than-expected revenue

Adient (NYSE:ADNT) reported Q3 adjusted EPS of $0.48, below the $0.57 consensus, while revenue rose to $3.93B versus a $3.7B forecast. The company cited about $32M in temporary headwinds and operational inefficiencies. Adient kept FY2026 guidance, expecting ~$15B revenue, and reported GAAP net income of $25M. Shares were down ~0.9% premarket.

$ADNTMedAI 8/10

Adient reports third quarter financial results; reaffirms earnings and FCF outlook for FY26

Adient (NYSE: ADNT) reported Q3 2026 results: GAAP net income of $25M and diluted EPS of $0.32, versus adjusted diluted EPS of $0.48. Adjusted EBITDA was $225M, roughly flat year over year despite about $32M of temporary headwinds. At June 30, 2026, gross debt was ~$2.4B, net debt ~$1.5B, and cash ~$924M. The company said it generated free cash flow and repurchased $30M of shares in Q3.

$ADNTMed

Adient plc (ADNT): Results of Operations and Financial Condition

Adient plc (ADNT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a08052026adientexhibit991.htm EX-99.1 Document Exhibit 99.1 Appendix Page 1 Adient plc Condensed Consolidated Statements of Income (Loss) (Unaudited) Three Months Ended June 30, (in millions, except per share data) 2026 2025 Net sales $ 3,929 $ 3,741 Cost of sales 3,694

$ADNTLow

Adient plc (ADNT) Releases China Business Update

Adient plc (NYSE:ADNT) said in a May 20 China business update that since last year’s J.P. Morgan Summit it has received new bookings supporting sales growth. The company reported about $1.1 billion in annual business in FY2025 from four new auto brands, with ~70% from C-OEMs. It also noted a December 2025 JV via a 49% stake in SCI (Zhangjiakou) Co., Ltd.